<DOC>
	<DOCNO>NCT01725269</DOCNO>
	<brief_summary>The AIR001-CS05 study evaluate safety efficacy ( effectiveness ) AIR001 16 week subject PAH . The purpose AIR001-CS06 study evaluate intermediate / long-term safety AIR001 subject complete AIR001-CS05 study . Assessments evaluate effectiveness study drug include measurement exercise ability evaluation PAH disease symptom .</brief_summary>
	<brief_title>Long-term Study AIR001 Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05</brief_title>
	<detailed_description>The primary objective study evaluate intermediate/long-term safety inhale nebulized AIR001 administer accord 3 treatment arm ( 80 milligram ( mg ) 4 time daily , 46 mg 4 time daily , 80 mg daily ) subject World Health Organization ( WHO ) Group 1 Pulmonary Arterial Hypertension ( PAH ) complete 16-week AIR001-CS05 study .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<criteria>1 . Evidence personally sign date informed consent document indicate subject ( legally acceptable representative ) inform pertinent aspect study prior initiation subjectmandated procedure . 2 . Is willing able comply schedule visit , treatment plan , laboratory test , study procedure . 3 . Has complete 16week AIR001CS05study plan . 4 . If corticosteroid , receive stable dose less equal 20 mg/day prednisone ( equivalent dose , corticosteroid ) least 1 month ( 30 day ) prior AIR001CS05 study Baseline/Day 1 visit . If receive treatment Connective Tissue Disease ( CTD ) drug , dos remain stable , clinically feasible , duration AIR001CS06 study . 5 . Women childbearing potential must use least one form medically acceptable contraception ( i.e . either oral , topical , implanted hormonal contraceptive , intrauterine device ) two barrier method ; negative pregnancy test Screening Baseline/Day 1 agree use reliable method contraception least 24hours last dose study drug . Women surgically sterile ( i.e . hysterectomy , bilateral oophorectomy , tubal ligation ) postmenopausal least 2 year consider childbearing potential . Men sterile ( i.e . vasectomy ) must also agree use contraception least 24hours last dose study drug . 1 . Participation device interventional clinical study ( AIR001CS05 ) , within 1 month ( 30 day ) Baseline/Day 1 and/or study participation . 2 . Has uncontrolled systemic hypertension evidence sit systolic blood pressure &gt; 160 mmHg sit diastolic blood pressure &gt; 100 mmHg Baseline/Day 1 visit . 3 . Systolic blood pressure &lt; 90 mmHg Baseline/Day 1 . 4 . Diagnosis Down syndrome . 5 . Moderate severe hepatic impairment classify ChildPugh Class B C Baseline/Day 1 . 6 . Has chronic renal insufficiency define serum creatinine &gt; 2.5 mg/dL estimate Glomerular Filtration Rate ( eGFR ) &lt; 30 mL/min Baseline/Day 1 , require dialytic support . 7 . Has hemoglobin ( Hgb ) concentration &lt; 8.5 g/dL Baseline/Day 1 . 8 . Personal family history following : 1 . Congenital acquire methemoglobinemia ; 2 . RBC CYPB5 reductase deficiency . 9 . History glucose6phosphate dehydrogenase ( G6PD ) deficiency contraindication receive methylene blue . 10 . For subject Human immunodeficiency virus ( HIV ) associate PAH , requirement use inhale pentamidine . 11 . The use oral topical nitrate ( nitroglycerin , glyceryl trinitrate ( GTN ) , isosorbide dinitrate , isosorbide mononitrate ) within 1 month ( 30 day ) prior Baseline/Day 1 throughout AIR001CS06 study EOS Termination visit . Note : Intravenous GTN emergency set may administer start low dose titrate upward , subject monitor closely change blood pressure heart rate . 12 . Known suspected hypersensitivity allergic reaction sodium nitrite sodium nitrate . 13 . History malignancy within 5years prior Baseline/Day 1 AIR001CS05 study , exception localize nonmetastatic basal cell carcinoma skin situ carcinoma cervix . 14 . Other severe acute chronic medical laboratory abnormality may increase risk associate study participation investigational product administration may interfere interpretation study result , judgment investigator , would make subject inappropriate entry study . 15 . Has psychiatric , addictive disorder compromise ability give inform consent participate study . This include subject recent history abuse alcohol illicit drug 1 month ( 30 day ) prior study Baseline/Day 1 AIR001CS05 study duration study . 16 . Is currently pregnant breastfeed intend become pregnant duration study . 17 . Investigators , study staff immediate family .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>AIR001</keyword>
	<keyword>sodium nitrite</keyword>
	<keyword>PAH</keyword>
	<keyword>Pulmonary Arterial Hypertension</keyword>
	<keyword>inhaled sodium nitrite</keyword>
</DOC>